Targeted therapy in advanced non-small cell lung cancer: current advances and future trends
Umair Majeed(Mayo Clinic in Florida), Yanyan Lou(Jacksonville College)
Cited by 271
Related Papers
Next generation of immune checkpoint inhibitors and beyond
|Journal of Hematology & Oncology|2021|537
Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial
|Journal for ImmunoTherapy of Cancer|2022|140
The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer
|Annals of Oncology|2022|138